The tumor cell killing ability was significantly increased when HepG2 were treated with Ad-hTERTp-IL24 in combination with 5-Fu, compared with Ad-hTERTp-IL24 or 5-Fu treatment alone (Figure 4D). Here, IL24 is linked to neoplasm.